Navigation Links
Codexis Names Fernando Valle Research Fellow
Date:11/4/2009

REDWOOD CITY, Calif., Nov. 4 /PRNewswire/ -- Codexis, Inc. today announced that Fernando Valle, Ph.D., has joined the company as Codexis' first Research Fellow. Dr. Valle, a distinguished researcher in metabolic and genetic engineering over a nearly 30-year career in industrial biotechnology, will focus on Codexis' advanced biofuels programs. He will report to Lori Giver, Ph.D., Vice President, Synthetic Biology.

Dr. Valle joins Codexis from LS9, where he was Senior Director, Metabolic Engineering. Previously, he held a series of senior research positions with Genencor over 10 years, including Director, Metabolic Pathway Engineering. He holds a Ph.D in molecular biology and biotechnology from the National University of Mexico, and also held research positions at that university's Institute of Biotechnology. He is named on 14 issued U.S. patents and is an author on more than 50 scientific articles in the genetic engineering field.

"Fernando Valle is one of our industry's leading experts in metabolic engineering and in developing technology for real world commercial applications," said David Anton, Ph.D., Senior Vice President, Research and Development. "While at Genencor, he played a pivotal role in developing the successful metabolic pathway leading to commercial scale production of the chemical intermediate 1,3-propanediol (PDO, used in a wide variety of industrial applications ranging from carpet to airplane deicing fluids). We are delighted to welcome him to Codexis and our research leadership team. Codexis' ability to attract world class talent like Fernando is a clear indication of our preeminent position in cellular engineering."

Codexis, Inc. is a clean technology company. The company develops industrial biocatalysts, including enzymes and microbes, for the energy, pharmaceutical and environmental industries. Codexis serves major worldwide markets where clean technology can make a positive economic and environmental impact. For more information, visit www.codexis.com.

Contact: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771.

SOURCE Codexis, Inc.


'/>"/>
SOURCE Codexis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Veridiam Names Robert Mazzacavallo New CFO
2. Hospira Names Daphne E. Jones Chief Information Officer
3. Premier Research Names Bernard Sweeney as Executive Director, Medical Devices
4. American Hospital Association (AHA) Names OnBase RACTrac Compatible
5. ThermoGenesis Names Jorge Artiles Vice President, Chief Quality and Regulatory Affairs Officer
6. NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
7. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
8. ParagonRx Names Ellen M. Derrico To Chief Marketing Executive Post
9. Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO
10. California Cryobank Names Richard Jennings President of FamilyCord Division
11. Association of Clinical Research Organizations (ACRO) Names Dr. Derek Winstanly Chair-Elect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
Breaking Medicine News(10 mins):